Klaudia Lepka

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

High socioeconomic impact on prescription behavior despite unrestricted access to disease-modifying therapies in people with multiple sclerosis.

High socioeconomic impact on prescription behavior despite unrestricted access to disease-modifying therapies in people with multiple sclerosis.

Journal: Frontiers in immunology

Published: July 02, 2024

Glutaredoxin 2 promotes SP-1-dependent CSPG4 transcription and migration of wound healing NG2 glia and glioma cells: Enzymatic Taoism.

Glutaredoxin 2 promotes SP-1-dependent CSPG4 transcription and migration of wound healing NG2 glia and glioma cells: Enzymatic Taoism.

Journal: Redox biology

Published: October 18, 2021

Relapse-independent multiple sclerosis progression under natalizumab.

Relapse-independent multiple sclerosis progression under natalizumab.

Journal: Brain communications

Published: April 25, 2021

Association of Retinal Layer Thickness With Cognition in Patients With Multiple Sclerosis.

Association of Retinal Layer Thickness With Cognition in Patients With Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: December 09, 2020

Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS.

Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 02, 2020

Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.

Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.

Journal: Brain : a journal of neurology

Published: September 09, 2019

Factors associated with headache in intravenous immunoglobulin treatment for neurological diseases.

Factors associated with headache in intravenous immunoglobulin treatment for neurological diseases.

Journal: Acta neurologica Scandinavica

Published: March 01, 2019

Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatment.

Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatment.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: October 12, 2018

The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.

The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.

Journal: Acta neuropathologica

Published: June 06, 2018

Iron-sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microglia.

Iron-sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microglia.

Journal: Glia

Published: February 24, 2017

Redox Events As Modulators of Pathology and Therapy of Neuroinflammatory Diseases.

Redox Events As Modulators of Pathology and Therapy of Neuroinflammatory Diseases.

Journal: Frontiers in cell and developmental biology

Published: May 12, 2016

Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.

Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.

Journal: Journal of neuroinflammation

Published: October 21, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026